182 related articles for article (PubMed ID: 32904905)
1. Efficacy and safety of ropivacaine HCl in peribulbar anaesthesia for cataract surgery in patients with myotonic dystrophy type 1.
Palladino A; De Bernardo M; Scutifero M; Lanza M; De Querquis S; Rosa N; Politano L
Acta Myol; 2020 Jun; 39(2):90-93. PubMed ID: 32904905
[TBL] [Abstract][Full Text] [Related]
2. [Problems of perioperative period in patients with Steinert's myotonic dystrophy operated due to cataract].
Zalewska R; Mariak Z; Markowska E; Czaban S
Klin Oczna; 2005; 107(1-3):113-4. PubMed ID: 16052818
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized double-blinded controlled study of ropivacaine 0.75% versus bupivacaine 0.5%-mepivacaine 2% for peribulbar anesthesia.
Luchetti M; Magni G; Marraro G
Reg Anesth Pain Med; 2000; 25(2):195-200. PubMed ID: 10746534
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.
Gamet A; Degand B; Le Gal F; Bidegain N; Delaubier A; Gilbert-Dussardier B; Christiaens L; Garcia R
Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12587. PubMed ID: 30101452
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and comparison of 0.5% levobupivacaine with 0.75% ropivacaine for peribulbar anaesthesia in cataract surgery.
Di Donato A; Fontana C; Lancia F; Celleno D
Eur J Anaesthesiol; 2006 Jun; 23(6):487-90. PubMed ID: 16507188
[TBL] [Abstract][Full Text] [Related]
6. Gender effect on onset, prevalence and surgical treatment of cataract in patients with Myotonic Dystrophy type 1.
Scutifero M; Lanza M; Petillo R; De Bernardo M; Passamano L; Rosa N; Politano L
Acta Myol; 2022; 41(3):105-110. PubMed ID: 36349183
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and pharmacokinetics of 1% ropivacaine and 0.75% bupivacaine in peribulbar anaesthesia for cataract surgery.
Huha T; Ala-Kokko TI; Salomäki T; Alahuhta S
Anaesthesia; 1999 Feb; 54(2):137-41. PubMed ID: 10215708
[TBL] [Abstract][Full Text] [Related]
8. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
[TBL] [Abstract][Full Text] [Related]
9. The heart and cardiac pacing in Steinert disease.
Nigro G; Papa AA; Politano L
Acta Myol; 2012 Oct; 31(2):110-6. PubMed ID: 23097601
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 1% ropivacaine and a mixture of 2% lignocaine and 0.5% bupivacaine for peribulbar anaesthesia in cataract surgery.
Corke PJ; Baker J; Cammack R
Anaesth Intensive Care; 1999 Jun; 27(3):249-52. PubMed ID: 10389555
[TBL] [Abstract][Full Text] [Related]
11. [Topical anesthesia for cataract surgery with phacoemulsification: lidocaine 2% vs ropivacaine 1%. Preliminary results].
Lo Martire N; Savastano S; Rossini L; Pinchera L; Caracciolo F; Savastano MC; Rossini P; Panariti R; Mondello E; Epifanio A
Minerva Anestesiol; 2002 Jun; 68(6):529-35. PubMed ID: 12105409
[TBL] [Abstract][Full Text] [Related]
12. [Cardiac, respiratory and sleep disorders in patients with myotonic dystrophy].
Banach M; Rakowicz M; Antczak J; Rola R; Witkowski G; Waliniowska E
Przegl Lek; 2009; 66(12):1065-8. PubMed ID: 20514907
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized, double-blinded comparison of ropivacaine 0.5%, 0.75%, and 1% ropivacaine for peribulbar block.
Gioia L; Fanelli G; Casati A; Nuti U; Mennella R; Scarioni M; Cerchierini E; Sciascia A; Garassino A; Torri G; Fasce F; Bolognesi G
J Clin Anesth; 2004 May; 16(3):184-8. PubMed ID: 15217657
[TBL] [Abstract][Full Text] [Related]
14. [When do you implant a pacemaker in myotonic dystrophy?].
Babuty D; Lallemand B; Laurent V; Clémenty N; Pierre B; Fauchier L; Raynaud M; Pellieux S
Presse Med; 2011; 40(7-8):748-53. PubMed ID: 21549556
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study.
Petri H; Witting N; Ersbøll MK; Sajadieh A; Dunø M; Helweg-Larsen S; Vissing J; Køber L; Bundgaard H
Int J Cardiol; 2014 Jun; 174(1):31-6. PubMed ID: 24704412
[TBL] [Abstract][Full Text] [Related]
16. Natural history of cardiac involvement in myotonic dystrophy type 1 - Emphasis on the need for lifelong follow-up.
Petri H; Mohammad BJY; Kristensen AT; Thune JJ; Vissing J; Køber L; Witting N; Bundgaard H; Christensen AH
Int J Cardiol; 2024 Jul; 406():132070. PubMed ID: 38643802
[TBL] [Abstract][Full Text] [Related]
17. Cardiac involvement in myotonic muscular dystrophy.
Moorman JR; Coleman RE; Packer DL; Kisslo JA; Bell J; Hettleman BD; Stajich J; Roses AD
Medicine (Baltimore); 1985 Nov; 64(6):371-87. PubMed ID: 4058303
[TBL] [Abstract][Full Text] [Related]
18. Ropivacaine for peribulbar anesthesia.
Nicholson G; Sutton B; Hall GM
Reg Anesth Pain Med; 1999; 24(4):337-40. PubMed ID: 10445773
[TBL] [Abstract][Full Text] [Related]
19. Ropivacaine versus lidocaine for deep-topical, nerve-block anaesthesia in cataract surgery: a double-blind randomized clinical trial.
Ugur B; Dundar SO; Ogurlu M; Gezer E; Ozcura F; Gursoy F
Clin Exp Ophthalmol; 2007 Mar; 35(2):148-51. PubMed ID: 17362456
[TBL] [Abstract][Full Text] [Related]
20. Progressive conduction disturbance in myotonic dystrophy.
Palazzolo J; Trucco E; Arce M; Riera AR; Femenía F
Cardiol J; 2011; 18(3):322-5. PubMed ID: 21660927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
